首页/数据集/Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial - SUPPLEMENTARY MATERIAL

Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial - SUPPLEMENTARY MATERIAL

NIAID Data Ecosystem2026-05-02 收录

红斑狼疮皮肤治疗

二期临床试验

数据链接：

https://data.mendeley.com/datasets/pfsydwvcj2 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary materials for the Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial manuscript.

应用场景：

创建时间：

2024-09-19

结直肠癌联合治疗

二期临床试验

This phase II trial studies the side effects and how well niraparib and panitumumab work in treating patients with colorectal cancer that has spread to other places in the body. Niraparib may stop the

NIAID Data Ecosystem80

Supplementary Material for: Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (carcinoid): Results from the Phase 2 ATLANT Study

神经内分泌肿瘤治疗

二期临床试验

Introduction: Lanreotide autogel (LAN) and temozolomide (TMZ) are guidelines-recommended monotherapies for thoracic neuroendocrine tumors (carcinoids; T-NETs) but prospective data for both combined an

NIAID Data Ecosystem30

Perspective on this Article from A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer

皮肤癌预防

二期临床试验

Perspective on this Article from A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin Cancer

NIAID Data Ecosystem20

S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer

结直肠癌靶向治疗

二期临床试验

This randomized phase II trial studies how well irinotecan hydrochloride and cetuximab with or without vemurafenib works in treating patients with colorectal cancer that has spread to nearby tissue or

NIAID Data Ecosystem40

A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...

激酶抑制剂

二期临床试验

Background: * The drug R935788 (fostamatanib disodium) is a kinase inhibitor (i.e., it interferes with cell communication and growth and may prevent tumor growth). * R935788 has shown promising activi

NIAID Data Ecosystem30

Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial - SUPPLEMENTARY MATERIAL

资源简介：

相关数据集